PT-141 (bremelanotide, sold as Vyleesi) is dosed at 1.75 mg under the skin about 45 minutes before sex, with no more than 1 dose in 24 hours and no more than 8 doses a month, per the FDA Vyleesi label. New to PT-141? Our PT-141 peptide guide explains what it is and how it works; this page covers the dose, timing, units and vial math.
PT-141 Dosage — Key Takeaways
- Standard dose: 1.75mg subcutaneous injection, 45 minutes before activity
- First-time dose: Start at 1mg to assess tolerance
- Nasal spray dose: about 8mg intranasal (trials that worked used 7.5–20mg), 30–60 minutes before
- Max frequency: Once per 24 hours, no more than 8 doses per month
- Works differently than Viagra: PT-141 acts on the brain's melanocortin receptors, not blood flow
- Works for both men and women — FDA-approved for female HSDD as Vyleesi
Working out a dose means knowing what a vial holds. See where to buy PT-141 for the current 10mg price, the batch certificate and cost per use.
PT-141 Dosage Chart — Quick Reference
If you're here for the numbers, here they are. This chart covers every common use case:
If you experience significant nausea at any step, stay at that dose for another session or drop back down. There's no rush. If you need guidance on injection technique, see our complete guide to injecting peptides.
PT-141 Dosage for Women
PT-141 is the only peptide with FDA approval specifically for female sexual dysfunction. The approved dose for women with HSDD is the same as the standard dose: 1.75mg subcutaneous, as needed.
The clinical evidence for women is actually stronger than for men, since the Phase 3 RECONNECT trial (Kingsberg et al., 2019) specifically enrolled premenopausal women with HSDD. Key findings:
- Significant increase in desire scores vs. placebo
- Significant decrease in distress related to low desire
- Effects observed within the first month of use
- Benefits maintained over 24 weeks of the study
Clayton et al. (2016) had previously shown in a Phase 2b dose-finding trial (327 women, 0.75, 1.25 or 1.75mg) that bremelanotide increased the number of satisfying sexual events and desire scores in premenopausal women with HSDD, with the most common adverse event being nausea (40% of patients, usually mild and decreasing over time).
Women who weigh under 60kg may want to start at an even lower dose — around 0.75–1mg — since body weight can influence how strongly the peptide hits. The nausea tends to be more pronounced in lighter individuals at the full dose.
For a broader look at options, our guide to peptides for libido and sexual health covers additional compounds that women have found helpful.
PT-141 Nasal Spray Dosage
PT-141 nasal spray is an alternative administration route that some people prefer because it doesn't require injections. The nasal PT-141 dosage that matches a 1.75mg injection is about 8mg per dose, sprayed intranasally 30–60 minutes before activity; the nasal trials that beat placebo used 7.5–20mg.
Why is the nasal dose higher than injectable? Bioavailability. When you inject PT-141 subcutaneously, nearly 100% of the peptide reaches systemic circulation. Nasal absorption is less efficient — per milligram, it gives roughly a fifth of the injection's peak blood level — so you need a higher dose to achieve the same effect.
The nasal route actually has some advantages: faster onset (effects can start within 15–20 minutes), potentially less nausea since the peptide enters through a different pathway, and obviously no needles. The downside is less consistent dosing — how deeply you inhale, nasal congestion, and spray technique all affect absorption.
Early Phase 2 research on intranasal bremelanotide (Diamond et al., 2006) used nasal dosing and found significant pro-erectile effects in men with ED, though the pharmaceutical development ultimately focused on the injectable route for more reliable dosing.
Subcutaneous vs Nasal: Which Route Is Better?
This depends entirely on what you prioritize.
Choose subcutaneous if...
You want consistent, reliable dosing with well-studied outcomes. Best for people who are comfortable with injections and want predictable results every time.
Choose nasal spray if...
You hate needles, want faster onset, or find that injectable PT-141 gives you too much nausea. Better for convenience and spontaneity.
Most experienced users end up preferring subcutaneous injection because the dosing is more precise and the effects are more predictable. But nasal spray is a perfectly valid option, especially if nausea is a problem for you at the injectable dose.
One thing to keep in mind: nasal sprays require proper reconstitution and a reliable spray bottle that delivers consistent volumes. A poorly calibrated spray can result in dramatically different doses each time, which makes it harder to find your sweet spot. If you go the nasal route, invest in a quality metered-dose nasal spray device.
PT-141 Dosage by Body Weight
The FDA-approved dose of 1.75mg is a flat dose — meaning it's the same regardless of body weight. Clinical trials didn't adjust for weight. However, anecdotal reports and pharmacological logic suggest body weight does matter for PT-141 dosage.
Think about it: a 60kg woman and a 110kg man are getting the same amount of peptide distributed through very different volumes of tissue. The lighter person will have a higher effective concentration.
These are general guidelines, not strict rules. The most important thing is to start with a test dose regardless of your weight and adjust based on your individual response. Some heavy people respond perfectly at 1.5mg, and some lightweight people tolerate 1.75mg without issue.
How to Reconstitute PT-141 (10mg Vial + BAC Water Math)
PT-141 comes as a lyophilized (freeze-dried) powder that you need to reconstitute with bacteriostatic water before use. Here's exactly how to do it with a 10mg vial.
Step-by-Step Reconstitution
- Gather supplies: PT-141 10mg vial, bacteriostatic (BAC) water, insulin syringes (1ml/100 unit), alcohol swabs
- Clean the vial tops with alcohol swabs and let them air dry
- Draw BAC water: Pull your chosen amount of BAC water into a syringe
- Inject slowly: Push the BAC water into the PT-141 vial, aiming the stream at the glass wall — never blast it directly onto the powder
- Swirl gently: Don't shake. Let it dissolve naturally or roll the vial between your palms
- Store: Keep reconstituted PT-141 in the refrigerator. It stays good for about 4 weeks
Reconstitution Math Made Simple
The amount of BAC water you add determines your concentration. Here's the math for a 10mg vial:
Easiest option: Add 2ml of BAC water to a 10mg vial. This gives you 5mg/ml, making the math clean: every 10 units on your syringe = 0.5mg of PT-141. So 35 units = 1.75mg (the standard dose).
A 10mg vial reconstituted this way gives you approximately 5–6 full doses at 1.75mg, or up to 10 doses if you use the lower 1mg starting dose. For more detailed injection instructions, check our how to inject peptides guide.
When to Take PT-141 — Timing Matters
PT-141 timing is different from Viagra timing, and getting it right makes a real difference in your experience.
Inject 45 minutes to 1 hour before anticipated activity. This gives the peptide enough time to activate melanocortin receptors and initiate the arousal cascade.
Here's the timeline you can expect:
- 15–30 minutes: You may start feeling a subtle warmth, mild flushing, or slight nausea. These are signs it's absorbing.
- 30–60 minutes: Arousal effects begin. Most people notice increased sensitivity and a heightened sense of desire.
- 1–3 hours: Peak effects. This is the optimal window.
- 4–8 hours: Effects gradually taper. Many people report residual effects lasting well beyond the peak.
- 12–24 hours: Some users report lingering low-level effects even the next day.
Food and PT-141 Timing
Take PT-141 on a relatively empty stomach if nausea is a concern. A full meal can slow absorption and also seems to increase the chances of feeling nauseous. If you're planning a date night, consider eating a light meal 2–3 hours before injecting, rather than injecting right after a big dinner.
Alcohol and PT-141
Moderate alcohol consumption doesn't directly interfere with PT-141's mechanism of action (since they work on completely different systems). However, heavy drinking can blunt arousal regardless of what peptides you take, and alcohol on top of the nausea and flushing PT-141 can cause may leave you lightheaded. (PT-141 raises blood pressure slightly and slows the heart rate a little; it does not lower blood pressure.) Keep it to 1–2 drinks if you're using PT-141 that evening.
How Often Can You Use PT-141?
This is one of the most common questions about dosing frequency, and the answer has both a medical limit and a practical recommendation.
Medical limit: No more than once every 24 hours, and no more than 8 times per month. These are the FDA-prescribed limits based on safety data from the RECONNECT trial.
Practical recommendation: Most experienced users find that 2–4 times per month is the sweet spot. Using PT-141 too frequently can lead to diminishing returns — the melanocortin receptors may temporarily downregulate with repeated stimulation.
Why the 8x/month limit? The label gives two reasons: few phase 3 patients used more than 8 doses a month, and more frequent dosing raises the risk of focal skin darkening and lengthens the time each month that blood pressure is raised. Each dose lifts blood pressure by up to 6 mmHg systolic and 3 mmHg diastolic, peaking 2 to 4 hours after the shot and usually back to baseline within 12 hours (Vyleesi label).
If you find that PT-141 is becoming less effective, take a break for 2–3 weeks to let your receptors reset. This is similar to how other receptor-targeted compounds can develop temporary tolerance.
For those looking at peptides for erectile dysfunction, PT-141 works best as an as-needed tool rather than a daily protocol.
What to Expect — Timeline After Injection
Here's a realistic picture of what happens after you inject PT-141, based on thousands of user reports and clinical trial data.
The nausea, if it happens, usually starts within an hour of the dose and lasts about two hours (label median). It's rarely severe enough to be a deal-breaker, especially at the right dose. Some tricks that help: take it on a light stomach, stay hydrated, and avoid lying flat right after injection.
The arousal from PT-141 feels different from Viagra-induced erections. Users consistently describe it as a genuine increase in desire — you actually want sex, rather than just having the physical capability. Many describe it as feeling like they did in their 20s, where the drive comes naturally rather than being mechanically produced.
PT-141 Side Effects by Dose
PT-141 side effects are dose-dependent, which is why getting your PT-141 dosage right is so important. Here's what to expect at different doses:
The 1.75mg column uses the FDA label's pooled phase 3 (RECONNECT) numbers: 627 women on bremelanotide against 620 on placebo. The 1mg and 2mg+ columns are rough user-reported estimates, not trial results. Nausea was the most common side effect at 40%. It was worst after the first dose (21% of patients) and fell to about 3% after later doses, but 13% needed an anti-nausea drug and 8% stopped treatment because of it (Vyleesi label).
For a complete breakdown, read our PT-141 side effects guide.
Managing Nausea
If nausea is an issue for you:
- Lower your dose — try 1.25mg instead of 1.75mg
- Take it on a light stomach (not empty, not full)
- Stay upright for 30 minutes after injection
- Try ginger tea or ginger capsules 30 minutes before your dose
- Consider switching to nasal spray, which tends to cause less GI upset
- Give it time — nausea often decreases with subsequent doses
Blood Pressure Considerations
PT-141 causes a transient increase in blood pressure of up to 6 mmHg systolic and 3 mmHg diastolic, with a drop in heart rate of up to 5 beats per minute. For most healthy people, this is small. The label lists uncontrolled hypertension and known cardiovascular disease as contraindications. However, if you have uncontrolled hypertension or cardiovascular disease, talk to your doctor before using PT-141. The blood pressure effect usually resolves within 12 hours.
The blood pressure rise peaks 2 to 4 hours after the dose and usually returns to baseline within 12 hours. The label found no build-up when doses were taken 24 hours apart for up to 16 days (Vyleesi label).
PT-141 vs Viagra vs Cialis
Different problem, different drug.
The key difference: PT-141 creates desire. PDE5 inhibitors create ability. They address fundamentally different problems, which is why some people use both — PT-141 for the mental/desire component and a PDE5 inhibitor for the vascular/mechanical component.
Can you combine them? Some people do, but there's no clinical data on the combination. The blood pressure effects could theoretically stack (PT-141 raises BP slightly while PDE5 inhibitors lower it), which might actually balance out — but this hasn't been formally studied. If you try it, start with lower doses of both.
Where to Buy PT-141
Quality matters enormously with peptides. Under-dosed or contaminated PT-141 won't work properly and could cause unexpected side effects. Always buy from vendors who provide third-party certificates of analysis (COA) for every batch. Our current pick is Ascension Peptides; you can browse their full catalog (affiliate link) for availability updates and other compounds. We've consistently recommended Ascension because every vial comes with third-party HPLC and mass spec testing.
For a broader comparison of vendors, see our best peptide source 2026 roundup and our PT-141 for sale guide. We also cover where to buy PT-141 and tirzepatide in a combined sourcing article.
PT-141 Storage and Handling
Before Reconstitution
Unreconstituted PT-141 powder is stable at room temperature for extended periods, but it's best practice to store it in the refrigerator or freezer for maximum shelf life. Keep it away from direct sunlight.
After Reconstitution
Once you've added BAC water, store the vial in the refrigerator (2–8°C / 36–46°F). Reconstituted PT-141 remains stable for approximately 4 weeks when refrigerated. Don't freeze reconstituted solution — this can damage the peptide structure.
Always use a fresh alcohol swab on the vial stopper before drawing a dose. If the solution becomes cloudy or discolored, discard it.
Common Dosing Mistakes to Avoid
After reviewing thousands of user experiences and clinical data, these are the most common dosing mistakes:
Starting Too High
Jumping straight to 1.75mg or higher without a test dose. This is the #1 cause of bad first experiences — overwhelming nausea that puts people off the compound entirely.
Using It Too Often
Taking PT-141 more than twice a week. Receptor downregulation kicks in, and you'll need more to get the same effect — a losing cycle.
Wrong Timing
Taking it 10 minutes before or expecting instant effects. PT-141 needs 30–60 minutes to work through the melanocortin pathway. Plan ahead.
Poor Reconstitution
Using regular sterile water instead of bacteriostatic water, or shaking the vial violently. Both can damage or contaminate the peptide.
Stacking PT-141 With Other Peptides
Some users combine PT-141 with other peptides for synergistic effects. Common stacks include:
- PT-141 + Oxytocin nasal spray: Some report enhanced emotional connection and arousal. Separate timing — oxytocin 15 min before, PT-141 45 min before.
- PT-141 + BPC-157: Not for direct sexual benefits, but some users (see the BPC-157 dosage guide) who take BPC-157 for gut healing report it reduces PT-141-related nausea.
- PT-141 + Growth hormone secretagogues: Some long-term protocols include PT-141 alongside GH peptides for overall vitality. These don't interact directly.
PT-141 should not be combined with other melanocortin agonists (like Melanotan II) since they compete for the same receptors and the side effects would compound.
Related comparisons: PT-141 vs Melanotan 2 and kisspeptin vs PT-141.
PT-141 Dosage FAQ
Start with 1mg subcutaneous to test your tolerance. If you handle it well with minimal nausea, increase to 1.5mg, then to the standard 1.75mg on subsequent uses. Never start at the full dose on your first try.
Subcutaneous PT-141 typically starts working within 30–60 minutes, with peak effects at 1–2 hours. Nasal spray can onset faster, around 15–30 minutes. Plan to inject about 45 minutes before anticipated activity for best results.
No. PT-141 should not be used more than once every 24 hours, with a maximum of 8 doses per month. Using it daily would likely lead to receptor downregulation (diminishing effects) and more side effects. The label notes that 38% of people given PT-141 daily for 8 days developed focal skin darkening.
Yes — with an important caveat. PT-141 increases sexual desire and arousal through the brain, which can lead to erections. It's particularly effective for men whose ED has a psychological or desire-based component. For purely vascular ED, a PDE5 inhibitor may work better, though some men use both together.
Nasal spray can be effective but is generally less consistent than subcutaneous injection. The lower bioavailability (roughly a fifth of the injection's peak per mg) means you need a higher dose (about 8mg vs 1.75mg), and absorption varies based on nasal congestion and spray technique. Injection gives more predictable results.
At the standard 1.75mg dose, a 10mg vial provides approximately 5–6 doses (10 ÷ 1.75 = 5.7). If you use the lower 1mg starting dose, you'll get about 10 doses per vial.
Absolutely. PT-141 (bremelanotide/Vyleesi) is actually FDA-approved specifically for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD); it is not approved for postmenopausal women or men. The standard dose for women is the same as for men: 1.75mg subcutaneous. It's the only FDA-approved on-demand treatment for female low desire.
Lower your dose (try 1–1.25mg), take it on a light stomach, stay upright for 30 minutes after injection, and consider ginger tea before dosing. Nausea usually improves with subsequent uses. If it persists, try nasal spray instead — it tends to cause less GI upset.
Some people do combine them since they work through completely different mechanisms (PT-141 = brain/desire, Viagra/Cialis = blood flow). There's no clinical data on the combination, so if you try it, use lower doses of both and monitor how you feel. The blood pressure effects could theoretically interact.
Refrigerate at 2–8°C (36–46°F) after reconstituting with bacteriostatic water. It stays stable for approximately 4 weeks. Don't freeze reconstituted solution, and discard if the solution becomes cloudy or discolored.
The label says the duration of effect after each dose is unknown. What is measured: blood levels peak about 1 hour after the shot, the half-life is about 2.7 hours (range 1.9 to 4.0), and the small blood pressure rise is usually gone within 12 hours. That is why it is dosed before an occasion rather than daily.
The standard dose is the same for both — 1.75mg subcutaneous. However, women who weigh under 60kg may benefit from starting at a lower dose (0.75–1mg) since the peptide can hit harder at lower body weights. The clinical trials that led to FDA approval used 1.75mg for all participants regardless of sex.
Who Should Avoid PT-141?
PT-141 is generally well-tolerated, but certain people should avoid it or use it with extra caution:
- Uncontrolled hypertension: The transient blood pressure increase, while small, could be risky if your baseline is already elevated
- Cardiovascular disease: Anyone with active heart conditions should consult their cardiologist first
- Pregnant or breastfeeding women: No safety data exists for these populations
- People taking antihypertensive medications: Potential interactions with blood pressure management
- Those prone to pigment changes: In phase 3, focal skin darkening (face, gums, breasts) appeared in 1% of people using up to 8 doses a month, more often in darker skin, and did not always fade after stopping (Vyleesi label)
- People taking oral naltrexone for alcohol or opioid addiction: PT-141 can sharply lower naltrexone levels, and the label says to avoid the combination
If you have kidney or liver impairment, the peptide may clear more slowly from your system. Start with a lower dose and give extra time between uses. The clinical trials excluded people with significant organ impairment, so the standard dosing recommendations may not apply.
PT-141 is not a replacement for addressing underlying health issues. If your low libido stems from hormonal imbalances, relationship issues, medication side effects, or chronic stress, the peptide may help symptomatically but won't fix the root cause. A healthcare provider can help identify and treat the underlying issue while you use PT-141 as a bridge.
For more on sourcing quality peptides safely, see our PT-141 for sale guide which covers vendor verification and what to look for in certificates of analysis.
References
- Kingsberg SA, Clayton AH, Portman D, et al. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstet Gynecol. 2019;134(5):899-908. PubMed
- Clayton AH, Althof SE, Kingsberg S, et al. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. Womens Health (Lond). 2016;12(3):325-337. PubMed
- Diamond LE, Earle DC, Rosen RC, Willett MS, Molinoff PB. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int J Impot Res. 2004;16(1):51-59. PubMed
- Pfaus JG, Shadiack A, Van Soest T, Tse M, Molinoff P. Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc Natl Acad Sci USA. 2004;101(27):10201-10204. PubMed
- Safarinejad MR. Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study. J Sex Med. 2008;5(4):887-897. (Retracted; listed for transparency, not relied on in this article.) PubMed
- Simon JA, Kingsberg SA, Portman D, et al. Long-term safety and efficacy of bremelanotide for hypoactive sexual desire disorder. Obstet Gynecol. 2019;134(5):909-917. PubMed
- VYLEESI (bremelanotide injection) prescribing information. FDA, NDA 210557 (approved June 21, 2019; label revised November 2025). Vyleesi label
The information in this article is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting any new supplement or compound. Results vary by individual.



